• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconweight-loss and diet control industry

weight-loss and diet control industry

Page 7 of 10
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
Health
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By Ryan HoggNovember 2, 2023
KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories
Europe
KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories
By Ryan HoggOctober 19, 2023
Eli Lilly
Health
New weight-loss blockbuster drug emerges from study showing Mounjaro helps people lose 25% of their body weight or 60 pounds on average
By Jonel Aleccia and The Associated PressOctober 15, 2023
ozempic injection picture
Finance
Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By Prarthana PrakashOctober 10, 2023
Weight-loss drugs like Ozempic and Wegovy come with potentially serious side effects, study finds
Health
Weight-loss drugs like Ozempic and Wegovy come with potentially serious side effects, study finds
By Madison Muller and BloombergOctober 5, 2023
Wegovy shots seen in a factory setting.
Lifestyle
Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By Chloe TaylorOctober 5, 2023
Weight-loss drugs like Ozempic and Wegovy may be risky for older people because they melt away all-important muscles, experts say
Health
Weight-loss drugs like Ozempic and Wegovy may be risky for older people because they melt away all-important muscles, experts say
By Madison Muller and BloombergSeptember 27, 2023
Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says
Health
Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says
By Angel Adegbesan and BloombergSeptember 22, 2023
TikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash
Tech
TikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash
By Alexandra SternlichtSeptember 19, 2023
Some weight loss pills used as alternatives to Ozempic and Wegovy contain toxic ingredients that are ‘potentially life-threatening’
Health
Some weight loss pills used as alternatives to Ozempic and Wegovy contain toxic ingredients that are ‘potentially life-threatening’
By Madison Muller and BloombergSeptember 14, 2023
a box of wegovy medication
Retail
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By Prarthana PrakashSeptember 5, 2023
Weight loss drugs are such big sellers now that Ozempic’s maker has overtaken LVMH as Europe’s most valuable company
Health
Weight loss drugs are such big sellers now that Ozempic’s maker has overtaken LVMH as Europe’s most valuable company
By Jonas Ekblom, Marthe Fourcade and BloombergSeptember 1, 2023
woman measuring her waist with a tape measure.
Health
Blockbuster weight loss drugs Ozempic and Wegovy cost Americans up to 10 times more than what other countries pay, research shows
By Christiaan HetznerAugust 18, 2023
wegovy drug
Health
A pharma company helping Elon Musk shed weight is now worth more than the entire economy of Denmark
By Prarthana PrakashAugust 11, 2023
Weight-loss stocks soar up to 15% after obesity-drug study shows an added benefit that may be a ‘huge win’ for future sales
Health
Weight-loss stocks soar up to 15% after obesity-drug study shows an added benefit that may be a ‘huge win’ for future sales
By Angel Adegbesan, Jameelah Robinson and BloombergAugust 8, 2023
1...
  • 5
  • 6
  • 7
  • 8
  • 9
10
Most Popular
Big Tech
Nvidia built a $5 trillion company while making employees pay for their own lunch—but they get far more lucrative perks like stock discountsplaceholder alt text
By Marco Quiroz-GutierrezOctober 10, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers—‘or you’re neurodivergent’placeholder alt text
By Preston ForeOctober 10, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeOctober 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.